Industry reports
Editor highlights

Publication dates

data types

Immunotherapy Market and Forecasts, April 2014

You might be interested in: insulin, vaccine, therapeutics, more »


 
1-10 of about 100 reports for Immunotherapy

Prostate Cancer Sector (prostate cancer, colorectal cancer, smallpox) in The United States and Canada

  • Industry report
  • January 2014
  • 34 pages

... Cadence pharmaceuticals, lilly, serono) as president of cancer immunotherapy division and executive vice president 4 recent highlights 5 pipeline infectious diseases preclinical phase 1 phase 1 ...

U.S. Biosimilar Sector Brief

  • Industry report
  • January 2013
  • 2 pages

... S. And british also plans to expand exploration of lake vostok. immunotherapy of cancer: the scientific community has recently developed a drug able to be drive the immune cells of body to fight cancer and help ...

Pharmaceutical Industry in The United States, France and India

  • Industry report
  • February 2012
  • 32 pages

... Market driven products and references square4 product portfolio - for allergic rhinitis - for asthma & c.O.P.D. - For pain - for vaccines, immunotherapy and anti- virals - for c.N.S. And other ...

Cancer Market in The United States, Australia and Canada

  • Industry report
  • January 2012
  • 13 pages

... To attack cancer cells and halt their out-of-control growth, as it has been shown to do with melanoma. - Rogress_in_cancer_immunotherapy ...

Global Biotechnology Market Overview

  • Industry report
  • February 2012
  • 28 pages

... To neurons misfolded sod1 switches to producing toxic reactive oxygen species Kills neurons superoxide dismutase 1 (sod1)- Jekyll and hyde protein 15 Propagation of sod1 misfolding: immunotherapy ...

Biotechnology Market in The United States

  • Industry report
  • March 2014
  • 25 pages
  • by Corporation

... Differentiated immunotherapy platform generating diverse pipeline with strong patent estate promising clinical data yielding impressive survival supports 2 programs advancing into late-stage studies in 2014 ...

Energy & Environment Business in The United States and China

  • Industry report
  • February 2012
  • 32 pages

... The consideration of innovative solutions to common diseases such as cancer and chronicle diseases. The main sectors regarding immunotherapy research are the monoclonal antibodies; they have been used only for ten ...

Pharmaceutical Business in Australia and The United States

  • Industry report
  • October 2012
  • 32 pages

... Www.Secdatabase.Com. All rights reserved. Please consider the environment before printing this document understanding immunotherapy summary data from ipilimumab phase iii trial of patients ...

The Indian Insulin Market : Innovation and Technology Trends

  • Industry report
  • May 2012
  • 33 pages
  • by Corporation

... immunotherapy, comprehensive care research services syngene (custom research) clinigene (clinical research) biosimilar biologics insulin & analogs; biosimilar mabs novel molecules in-105, itolizumab ...

The Indian Insulin Market : Innovation and Technology Trends

  • Industry report
  • April 2012
  • 32 pages
  • by Corporation

... Oncology, immunotherapy, comprehensive care research services syngene (custom research) clinigene (clinical research) biosimilar biologics insulin & analogs; biosimilar mabs novel molecules in-105 ...

» Purchase Premium Reports (From $ 125 - $ 8 995)

55 reports for Immunotherapy
Analytical Tool - Cancer Immunotherapy

Analytical Tool - Cancer Immunotherapy

  • $ 8 175
  • Industry report
  • March 2014
  • by Bioseeker

"Analytical Tool- Cancer Immunotherapy" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in immunotherapy drug development for the treatment of cancer. It ...


» Read our Company Profiles

1 Companies for Immunotherapy

Roche Holding AG

Switzerland

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.